The new single inhaler version of AstraZeneca’s asthma, Symbicort (budesonide and formoterol), reduces the number of severe asthma attacks and improves overall asthma control, according to the results ...
MADISON, Wis.--(BUSINESS WIRE)--Propeller Health, a leading digital health company dedicated to the management of asthma and COPD, today announced it has received 510(k) clearance from the U.S. Food ...
Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called ...
SAN FRANCISCO (MarketWatch) -- AstraZeneca PLC said Monday that results from a one-year study show that patients taking its Symbicort single-inhaler therapy had fewer asthma attacks and required less ...
Asthma affects 2 out of 10 people in Scotland and this chronic, variable, inflammatory disease is characterised by asthma attacks and symptoms including breathlessness and wheezing. [7] 'Mild' asthma ...
Subsidies for asthma inhalers will get a big shake-up from 1 August. More people will be able to have long-acting inhalers, such as Oxis and Serevent, because of relaxed prescribing rules which see ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback